findmyKOL
Clinical trialNCT01440088CompletedPhase 3Interventional

A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

SponsorThreshold PharmaceuticalsEnrollment640Soft Tissue Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • University Klinikum Graz

    Graz, Austria

  • Univ. Klinik Fur Innere Medizin I Internistische Onkologie Medizinische Universitat Innsbruck

    Innsbruck, Austria

  • Allgemeines Krankenhaus Wien

    Vienna, Austria

Belgium
  • Universitaire Ziekenhuizen (uz) Leuven - Gasthuisberg

    Leuven, Belgium

Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences - Department of Medicine

    Hamilton, Ontario, Canada

  • Mcgill University Health Centre

    Montreal, Quebec, Canada

  • Tom Baker Cancer Centre

    Calgary, Canada

  • Cross Cancer Institute

    Edmonton, Canada

  • Ottawa Health Research Institue

    Ottawa, Canada

  • Bcca- Vancouver Cancer Centre - Division of Medical Oncology

    Vancouver, Canada

  • Cancer Care Manitoba

    Winnipeg, Canada

Denmark
  • University Hospital Herlev at Copenhagen

    Herlev, Copenhagen, Denmark

France
  • Ico Rene Gauducheau

    Saint-Herblain, Nantes, France

  • Institut Bergonie

    Bordeaux, France

  • Departement D'Oncologie Medicale

    Dijon, France

  • Centre Leon Berard

    Lyon, France

  • Département D'Oncologie Moléculaire, Institut Paoli-Calmettes (ipc) and U119 Inserm

    Marseille, France

  • Centre Antoine Lacassagne

    Nice, France

  • Chu Strasbourg

    Strasbourg, France

  • Institut Claudius Regaud

    Toulouse, France

Germany
  • Helios Klinikum Berlin-Buch

    Berlin, Germany

  • Helios Klinikum Bad Saarow, Department of Hematology, Oncology, and Palliative Care, Sarcoma Center Berlin-Brandenburg

    Berlin, Germany

  • Universitätsklinikum Essen

    Essen, Germany

  • Krankenhaus Nordwest Gmbh

    Frankfurt, Germany

  • Medizinische Hochschule Hannover (mhh) - Klinik Fuer Haemonstaseologie, Onkologie Und Stammzelltransplantation

    Hanover, Germany

  • Div. of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center

    Mannheim, Germany

  • Wilhelm'S University, Universitatsklinikum Muenster, Medizinische Klinik Und Poliklinik A, Albert-Schweitzer-Campus 1

    Münster, Germany

Hungary
  • Magyar Honvedseg Honvedkorhaz, Onkologiai Osztaly

    Budapest, Hungary

  • Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Megyei Onkologiai Kozpont

    Szolnok, Hungary

Israel
  • Sharette Institute of Oncology, Hadassah-Hebrew University Medical Center, Hadassah Medical Org-Ein Karem

    Kiryat Hadassah, Jerusalem, Israel

Italy
  • Irccs Centro Di Riferimento Oncologico-Struttura Operativa

    Aviano, Pordenone, Italy

  • Fondazione del Piemonte Per L'Oncologia, Instituto Per la Ricerca E la Cura del Cancro (i.R.C.C.), Dipartimento Oncologico, Direzione Operativa Oncologia Medica A Direzione Universitaria

    Candiolo, Torino, Italy

  • Centro Di Riferimento Oncologico (cro)

    Aviano, Italy

  • Azienda Ospedaliera Garibaldi

    Catania, Italy

  • Azienda Ospedaliero Universitaria-Policlinico Paolo Giacco

    Palermo, Italy

  • Asl To/2 Di Torino_presidio Sanitario Gradenigo, S.C. Di Oncologia

    Torino, Italy

Poland
  • Wojewodzkie Centrum Onkologii

    Gdansk, Poland

  • Centrum Onkologii Instytut Im M. Sklodowskiej-Curie

    Krakow, Poland

  • Centrum Onkologii-Instytut Im. M. Sklodowskiej-Curie

    Warsaw, Poland

Russia
  • Guz "regional Oncology Dispensay", Kazan

    Kazan', Russia

52 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2011
Primary completion
31 Dec 2015
Completion
31 May 2016
Last update posted
2 Jun 2016
Registered enrollment
640
Registry id
NCT01440088

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.